Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching

Molecular Brain

Volumn 2, Issue 1, 2009, Pages

  Lu, Yubing ^a   Ferris, Jacob ^a   Gao, Fen Biao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; PROTEIN TDP-43;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; DROSOPHILA; EMBRYO; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE OVEREXPRESSION; GENETIC ANALYSIS; IN VIVO STUDY; LARVA; MALE; MUTANT; MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SENSORY NERVE CELL; ALLELE; ANIMAL; DENDRITIC SPINE; DROSOPHILA MELANOGASTER; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SENSORY RECEPTOR; SURVIVAL; TRANSGENIC ANIMAL;

ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DENDRITIC SPINES; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; FRONTOTEMPORAL DEMENTIA; HUMANS; MUTATION; SENSORY RECEPTOR CELLS; SURVIVAL ANALYSIS;

EID: 70350356317     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-2-30     Document Type: Article

References (37)

1. Clinical features of frontotemporal dementia. AL Boxer BL Miller, Alzheimer Dis Assoc Disord 2005 19 3 6 10.1097/01.wad.0000183086.99691.91 16317256
2. New approaches to the treatment of frontotemporal lobar degeneration. KA Vossel BL Miller, Curr Opin Neurol 2008 21 708 716 10.1097/WCO.0b013e328318444d 18989117
3. Frontotemporal lobar degeneration with FUS pathology. M Neumann R Rademakers S Roeber M Baker HA Kretzschmar IR Mackenzie, Brain 2009 19674978
4. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. M Hong V Zhukareva V Vogelsberg-Ragaglia Z Wszolek L Reed BI Miller DH Geschwind TD Bird D McKeel A Goate JC Morris KC Wilhelmsen GD Schellenberg JQ Trojanowski VM Lee, Science 1998 282 1914 1917 10.1126/science.282.5395.1914 9836646
5. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. M Hutton CL Lendon P Rizzu M Baker S Froelich H Houlden S Pickering-Brown, et al. Nature 1998 393 702 705 10.1038/31508 9641683
6. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. GD Watts J Wymer MJ Kovach SG Mehta S Mumm D Darvish A Pestronk MP Whyte VE Kimonis, Nat Genet 2004 36 377 381 10.1038/ng1332 15034582
7. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. G Skibinski NJ Parkinson JM Brown L Chakrabarti SL Lloyd H Hummerich JE Nielsen JR Hodges MG Spillantini T Thusgaard, et al. Nat Genet 2005 37 806 808 10.1038/ng1609 16041373
8. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. M Baker IR Mackenzie SM Pickering-Brown J Gass R Rademakers C Lindholm J Snowden J Adamson AD Sadovnick S Rollinson A Cannon E Dwosh D Neary S Melquist A Richardson D Dickson Z Berger J Eriksen T Robinson C Zehr CA Dickey R Crook E McGowan D Mann B Boeve H Feldman M Hutton, Nature 2006 442 916 919 10.1038/nature05016 16862116 (Pubitemid 44285946)
9. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. M Cruts I Gijselinck J van der Zee S Engelborghs H Wils D Pirici R Rademakers R Vandenberghe B Dermaut JJ Martin, et al. Nature 2006 442 920 924 10.1038/nature05017 16862115 (Pubitemid 44285947)
10. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. M Neumann DM Sampathu LK Kwong AC Truax MC Micsenyi TT Chou J Bruce T Schuck M Grossman CM Clark LF McCluskey BL Miller E Masliah IR Mackenzie H Feldman W Feiden HA Kretzschmar JQ Trojanowski VM Lee, Science 2006 314 130 133 10.1126/science.1134108 17023659
11. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. T Arai M Hasegawa H Akiyama K Ikeda T Nonaka H Mori D Mann K Tsuchiya M Yoshida Y Hashizume T Oda, Biochem Biophys Res Commun 2006 351 602 611 10.1016/j.bbrc.2006.10.093 17084815
12. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. NJ Cairns M Neumann EH Bigio IE Holm D Troost KJ Hatanpaa C Foong CL White 3rd JA Schneider HA Kretzschmar D Carter L Taylor-Reinwald K Paulsmeyer J Strider M Gitcho AM Goate JC Morris M Mishra LK Kwong A Stieber Y Xu MS Forman JQ Trojanowski VM Lee IR Mackenzie, Am J Pathol 2007 171 227 240 10.2353/ajpath.2007.070182 17591968 (Pubitemid 47342406)
13. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. JC Van Swieten P Heutink, Lancet Neurol 2008 7 965 974 10.1016/S1474-4422(08)70194-7 18771956
14. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. J Sreedharan IP Blair VB Tripathi X Hu C Vance B Rogelj S Ackerley JC Durnall KL Williams E Buratti F Baralle J de Belleroche JD Mitchell PN Leigh A Al-Chalabi CC Miller G Nicholson CE Shaw, Science 2008 319 1668 1672 10.1126/science. 1154584 18309045
15. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. E Kabashi PN Valdmanis P Dion D Spiegelman BJ McConkey C Vande Velde JP Bouchard L Lacomblez K Pochigaeva F Salachas PF Pradat W Camu V Meininger N Dupre GA Rouleau, Nat Genet 2008 40 572 574 10.1038/ng.132 18372902
16. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. NJ Rutherford YJ Zhang M Baker JM Gass NA Finch YF Xu H Stewart BJ Kelley K Kuntz RJ Crook J Sreedharan C Vance E Sorenson C Lippa EH Bigio DH Geschwind DS Knopman H Mitsumoto RC Petersen NR Cashman M Hutton CE Shaw KB Boylan B Boeve NR Graff-Radford ZK Wszolek RJ Caselli DW Dickson IR Mackenzie L Petrucelli R Rademakers, PLoS Genet 2008 4 1000193 10.1371/journal.pgen.1000193 18802454
17. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. F Geser M Martinez-Lage J Robinson K Uryu M Neumann NJ Brandmeir SX Xie LK Kwong L Elman L McCluskey CM Clark J Malunda BL Miller EA Zimmerman J Qian V Van Deerlin M Grossman VM Lee JQ Trojanowski, Arch Neurol 2009 66 180 189 10.1001/archneurol.2008.558 19204154
18. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. K Moisse K Volkening C Leystra-Lantz I Welch T Hill MJ Strong, Brain Res 2009 1249 202 211 10.1016/j.brainres.2008.10.021 19046946
19. TDP-43: an emerging new player in neurodegenerative diseases. IF Wang LS Wu CK Shen, Trends Mol Med 2008 312 479 485 10.1016/j.molmed.2008.09.001
20. TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons. I Casafont R Bengoechea O Tapia MT Berciano M Lafarga, J Struct Biol 2009 167 235 241 10.1016/j.jsb.2009.06.006 19539030
21. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. SH Ou F Wu D Harrich LF Garcia-Martinez RB Gaynor, J Virol 1995 69 3584 3596 7745706
22. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. E Buratti T Dörk E Zuccato F Pagani M Romano FE Baralle, EMBO J 2001 20 1774 1784 10.1093/emboj/20.7.1774 11285240
23. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. YM Ayala S Pantano A D'Ambrogio E Buratti A Brindisi C Marchetti M Romano FE Baralle, J Mol Biol 2005 348 575 588 10.1016/j.jmb.2005.02.038 15826655
24. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. IF Wang LS Wu HY Chang CK Shen, J Neurochem 2008 105 797 806 10.1111/j.1471-4159.2007.05190.x 18088371
25. The Microprocessor complex mediates the genesis of microRNAs. RI Gregory KP Yan G Amuthan T Chendrimada B Doratotaj N Cooch R Shiekhattar, Nature 2004 432 235 240 10.1038/nature03120 15531877
26. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. F Feiguin VK Godena G Romano A D'Ambrogio R Klima FE Baralle, FEBS Lett 2009 583 1586 1592 10.1016/j.febslet.2009.04.019 19379745
27. Genome-wide analyses identify transcription factors required for proper morphogenesis of Drosophila sensory neuron dendrites. JZ Parrish MD Kim LY Jan YN Jan, Genes Dev 2006 20 820 835 10.1101/gad.1391006 16547170
28. BTB/POZ-zinc finger protein Abrupt regulates dendritic branching in a neuronal subtype-specific and dosage-dependent manner. W Li F Wang L Menut F-B Gao, Neuron 2004 43 823 834 10.1016/j.neuron.2004.08.040 15363393
29. Mechanisms that regulate establishment, maintenance, and remodeling of dendritic fields. JZ Parrish K Emoto MD Kim YN Jan, Annu Rev Neurosci 2007 30 399 423 10.1146/annurev.neuro.29.051605.112907 17378766
30. Postnatal neurodevelopmental disorders: meeting at the synapse? HY Zoghbi, Science 2003 302 826 830 10.1126/science.1089071 14593168
31. Molecular and cellular mechanisms of dendritic morphogenesis. FB Gao, Curr Opin Neurobiol 2007 17 525 532 10.1016/j.conb.2007.08.004 17933513
32. Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. T Lee L Luo, Neuron 1999 22 451 461 10.1016/S0896-6273(00)80701-1 10197526
33. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. LM Igaz LK Kwong A Chen-Plotkin MJ Winton TL Unger Y Xu M Neumann JQ Trojanowski VM Lee, J Biol Chem 2009 284 8516 8524 10.1074/jbc.M809462200 19164285
34. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. C Haass DJ Selkoe, Nat Rev Mol Cell Biol 2007 8 101 12 10.1038/nrm2101 17245412
35. Neurodegenerative diseases target large-scale human brain networks. WW Seeley RK Crawford J Zhou BL Miller MD Greicius, Neuron 2009 62 42 52 10.1016/j.neuron.2009.03.024 19376066
36. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. A D'Ambrogio E Buratti C Stuani C Guarnaccia M Romano YM Ayala FE Baralle, Nuc Acids Res 2009 37 4116 6126 10.1093/nar/gkp342
37. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. BS Johnson D Snead JJ Lee JM McCaffery J Shorter1 AD Gitler, J Bio Chem 2009 284 20329 20339 10.1074/jbc.M109.010264